CALL FOR PAPERS

CERTIFICATE

IMPACT FACTOR 2019

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

 

 

 

 

 

 

 

 

 

 

 

Further news on coronavirus covid-19 from italy

Author: 
Giulio Tarro, MD, PhD
Subject Area: 
Social Sciences and Humanities
Abstract: 

Northern Italy, especially Lombardia and Veneto, has been affected by the COVID-19 coronavirus epidemic for weeks. Trying to isolate the carriers of the disease in connection with China is not an effective strategy to contain the disease, since the virus is transmitted like the flu virus and we can expect to have patients who have had no contact with possible carriers. According to Coronavirus genetic map, there are 3 isolated viruses in Italy. After that of Spallanzani (Rome) Covid 1 (Chinese), that of S. Raffaele Covid 2 (mutation of Chinese already known from the references) called Milanese, here is that of Sacco Hospital which is only a relative of the first two. It seems to be the same as that isolated in Finland, Germany, South America and it is hypothesized to have arrived in Europe long before the Chinese epidemic (November 2019 – March 2020). In Italy, however, the number of swabs and the procedures for carrying them out is essentially left to the arbitration of the Regions; a chaos that prevents any reference model from being determined. With this situation, it is not clear why among the various strategies that could have been adopted, after the home isolation of the population not engaged in certain work activities, there is even a quarantine for all people. Measure that it is not clear how long it can last.The real number of people infected in Italy is at least 4 or five times higher than that declared by the recovered patiens. Lombardia is the region in the first place for using tampons; this is the reason combined with the casual praxis to present as "coronavirus deaths" patients who, on the other hand, could have deaths associated with coronavirus (ie suffering from previous pathologies that caused death) that could explain the "mortality peak for COVID19" of Lombardia. It would be appropriate before identifying the primary cause of death in COVID19, carrying out the necessary pathological investigations and, above all, defining a standard to be applied throughout the national territory.

PDF file: 

IJMCE RECOMMENDATION

ONLINE PAYPAL PAYMENT

CURRENT ISSUE

NEWS

CHIEF EDITOR
Rosane Cavalcante Fragoso, Brasil
ASSOCIATE CHIEF EDITOR

   

Jean-Marc SABATIER
Chief Scientific Officer and Head of a Research Group
France

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

 

 

 

 

 

 

 

 

 

 

 

EDITORIAL BOARD

Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran